SENIOR MANAGEMENT

• Wayne Phillips CEO
• Market research UK
  INTERNATIONAL MARKET RESEARCH
  • Fabrice Allum: Board Director
  • Matthew Brooks: Director, Strategic MR
  • Anna Garofalo: Director, Strategic MR
  • Bridget Pumfrey: Director, Strategic MR
  • Sean Davies: Director, Strategic MR
  • Charlotte Savege: Director
  • Barry Crook: Director
  • Amanda Siebols: Research Consultant
• Market Research US
  INTERNATIONAL & US DOMESTIC
  MARKET RESEARCH
  • Jim Goldenberg: President
  • Thomas Hartford (T.H.) Kern: Senior Vice President, Strategic MR
  • Sally Davis: Senior Vice President,
    Strategic MR
    
  • Margie Sherr: Senior Vice President,
    Strategic MR
    
  • Andrea Stoltz: VP, Project Management
  • Rebekkah Carney: MIM VP, Medtech Market Research
  • Carolyn Ivins: Vice President
• Market Access and Consulting UK
  • Mike Mallinson: Managing Director
  • Shrinivas Rao Mukku: Lead Consultant, Global P&R
  • Robert White: Consultant
  • Enrico de Nigris: Consultant
  • Graeme Roberts: Consultant
  • Anna Gannedahl: Consultant
  • Henry Dummett: Consultant [Emerging Markets]
  • Ben Shankland: Consultant [Emerging Markets]
• Market Access and Consulting US
  • Michael Rizzo: Vice President
  • Caryn A. Zieses: Senior Consultant

Caryn Zieses

SENIOR CONSULTANT, DOUBLE HELIX CONSULTING US

czieses@dhelixc.com
Tel: 646 652 8508    Fax: 646 434 1896

Caryn joined Double Helix Consulting as a Senior Consultant in 2009 from the Pricing & Reimbursement consulting practice of IMS Health, formerly known as Cambridge Pharma Consultancy. As a global project manager at IMS, she worked closely with both large and small pharmaceutical and biotech clients to deliver global strategic recommendations that would inform decisions related to drug pricing, market access, clinical trial design, value messaging, payer attitudes, forecasting, and commercial assessments.

Her expertise in US payer trends spans both public and private organizations and the policy changes they continually face. She has extensive experience in a diverse set of therapy areas, in particular those related to neurosciences, pulmonology, immunology and ophthalmology. She also has four years of previous client services experience in the Equity Research division of Lehman Brothers.

Caryn holds an MBA from the Kellogg School of Management, an MEM from Northwestern University, and a BSE in Chemical Engineering from the University of Pennsylvania.